Complete antithrombin deficiency in mice results in embryonic lethality

Journal of Clinical Investigation

Volumn 106, Issue 7, 2000, Pages 873-878

  Ishiguro, Kazuhiro ^a   Kojima, Tetsuhito ^a,b   Kadomatsu, Kenji ^a   Nakayama, Yukiko ^a   Takagi, Akira ^b   Suzuki, Misao ^c   Takeda, Naoki ^c   Ito, Masafumi ^d   Yamamoto, Koji ^a   Matsushita, Tadashi ^a   Kusugami, Kazuo ^a   Muramatsu, Takashi ^a   Saito, Hidehiko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; FIBRINOGEN;

ANIMAL MODEL; ANTITHROMBIN DEFICIENCY; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; EMBRYO; EMBRYO DEATH; FIBRINOGEN SYNTHESIS; GENE DISRUPTION; GENOTYPE; HETEROZYGOSITY; LETHALITY; LIVER DYSFUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033807066     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10489     Document Type: Article

References (33)

1. Lane, D.A., and Caso, R. 1989. Antithrombin: structure, genomic organization, function and inherited deficiency. Baillieres Clin. Haematol. 2:961-998.
2. O'Reilly, M.S., Pirie-Shepherd, S., Lane, W.S., and Folkman, J. 1999. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science. 285:1926-1928.
3. Rosenberg, R.D., and Damus, P.S. 1973. The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 248:6490-6505.
4. Marcum, J.A., Fritze, L., Galli, S.J., Karp, G., and Rosenberg, R.D. 1983. Microvascular heparin-like species with anticoagulant activity. Am. J. Physiol. 245:H725-H733.
5. Marcum, J.A., and Rosenberg, R.D. 1984. Anticoagulantly active heparin-like species molecules from vascular tissue. Biochemistry. 23:1730-1737.
6. Rosenberg, R.D., Shworak, N.W., Liu, J., Schwartz, J.J., and Zhang, L. 1997. Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? J. Clin. Invest. 99:2062-2070.
7. Kojima, T., Leone, C.W., Marchildon, G.A., Marcum, J.A., and Rosenberg, R.D. 1992. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J. Biol. Chem. 267:4859-4869.
8. Kojima, T., Shworak, N.W., and Rosenberg, R.D. 1992. Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line. J. Biol. Chem. 267:4870-4877.
9. Ishiguro, K., et al. 2000. Syndecan-4 deficiency impairs focal adhesion formation only under restricted conditions. J. Biol. Chem. 275:5249-5252.
10. Egeberg, O. 1965. Inherited antithrombin III deficiency causing thrombophilia. Thromb. Diath. Haemorrh. 13:516-530.
11. Demers, C., Ginsberg, J.S., and Hirsh, J. 1992. Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review. Ann. Intern. Med. 116:754-761.
12. Lane, D.A., et al. 1997. Antithrombin mutation database: 2nd update. Thromb. Haemost. 77:197-211.
13. Lane, D.A., Kunz, G., Olds, R.J., and Thein, S.L. 1996. Molecular genetics of antithrombin deficiency. Blood Rev. 10:59-74.
14. Bayston, T.A., and Lane, D.A. 1997. Antithrombin: molecular basis of deficiency. Thromb. Haemost. 78:339-343.
15. Chowdhury, V., et al. 1994. Homozygous antithrombin deficiency: report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis. Thromb. Haemost. 72:198-202.
16. Okajima, K., et al. 1989. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto. Thromb. Haemost. 61:20-24.
17. Boyer, C., Wolf, M., Vedrenne, J., Meyer, D., and Larrieu, M.J. 1986. Homozygous variant of antithrombin III: ATIII Fontainebleau. Thromb. Haemost. 56:18-22.
18. Huang, Z.F., Higuchi, D., Lasky, N., and Broze, G.J., Jr. 1997. Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood. 90:944-951.
19. Healy, A.M., Rayburn, H.H., Rosenberg, R.D., and Weiler, H. 1995. Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system. Proc. Natl. Acad. Sci. USA. 92:850-854.
20. Wu, J.K., Scheffield, W.P., and Blajchman, M.A. 1992. Molecular cloning and cell-free expression of mouse antithrombin III. Thromb. Haemost. 68:291-296.
21. Tsuzuki, S., et al. 1997. Molecular cloning, genomic organization, promoter activity, and tissue-specific expression of the mouse ryudocan gene. J. Biochem. 122:17-24.
22. Igakura, T., et al. 1998. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in periimplantation development and spermatogenesis. Dev. Biol. 194:152-165.
23. Terauchi, Y., et al. 1999. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat. Genet. 21:230-235.
24. Liu, M.A. 1995. Overview of DNA vaccines. Ann. NY Acad. Sci. 772:15-20.
25. Chomczynski, P., and Sacchi, N. 1987. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
26. Yamamoto, K., and Loskutoff, D.J. 1996. Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J. Clin. Invest. 97:2440-2451.
27. Rosenberg, R.D., and Aird, W.C. 1999. Vascular-bed-specific hemostasis and hypercoagulable states. N. Engl. J. Med. 340:1555-1564.
28. Jalbert, L.R., et al. 1998. Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J. Clin. Invest. 102:1481-1488.
29. Maruyama, I., Bell, C.E., and Majerus, P.W. 1985. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J. Cell Biol. 101:363-371.
30. Yamanobe, F., Mochida, S., Ohno, A., Ishikawa, K., and Fujuwara, K. 1997. Recombinant human tissue factor pathway inhibitor as a possible anticoagulant targeting hepatic sinusoidal walls. Thromb. Res. 85:493-501.
31. Suh, T.T, et al. 1995. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 9:2020-2033.
32. McColl, M., et al. 1996. Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation. Blood Coagul. Fibrinolysis. 7:689-694.
33. Tait, R.C., et al. 1994. Prevalence of antithrombin deficiency in the healthy population. Br. J. Haematol. 87:106-112.